<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=780280282443813&amp;ev=PageView&amp;noscript=1">
search

    Sarepta Therapeutics, Inc.

    verified_userVerify Profile
    Companies » Health Care » Pharmaceuticals & Biotechnology » Pharmaceuticals

    About Sarepta Therapeutics, Inc.

    Sarepta Therapeutics is a U.S. commercial-stage biopharmaceutical company focused on the discovery and development of unique RNA-targeted therapeutics for the treatment of rare neuromuscular diseases. The Company is primarily focused on rapidly advancing the development of its potentially disease-modifying Duchenne muscular dystrophy (DMD) drug candidates. Source

    At A Glance

    • CAPITAL RAISE STATUS
      Not Currently Raising
    • FILING TYPE
      Public
    • PLATFORM TYPE
      NASDAQ
    • RAISED AMOUNT
      $X,XXX,XXX
    • PRE-MONEY EVAULATION
      $96,300,000
    • SIC CODE
      2834
    • NIN CODE
      ####
    • LEADERSHIP
      Douglas S. Ingram
    • FOUNDED
      1980
    • EMPLOYEES
      251-500
    • SECTOR
      Pharmaceuticals & Biotechnology
    • SUBSECTOR
      Pharmaceuticals

    Company Tags

    No articles found.

    Aviana Holdings Inc

    Aviana Holdings Inc

    Aviana Molecular Technologies, LLC (Aviana) is an Orlando, FL based point of care ...

    Aviana Molecular Technologies, LLC (Aviana) is ...

    Amount Raised:    $0.00
    Fundraising Status:    EC
    Filing Type:    CF
    Champions Oncology, Inc.

    Champions Oncology, Inc.

    Champions Oncology, Inc. is engaged in the development of advanced technology solu...

    Champions Oncology, Inc. is engaged in the deve...

    Filing Type:    PU
    Aduro Biotech, Inc.

    Aduro Biotech, Inc.

    Aduro is dedicated to its mission to discover, develop, and commercialize immunoth...

    Aduro is dedicated to its mission to discover, ...

    Filing Type:    PU
    AMAG Pharmaceuticals, Inc.

    AMAG Pharmaceuticals, Inc.

    Headquartered in Waltham, Massachusetts, we develop and deliver innovative medicin...

    Headquartered in Waltham, Massachusetts, we dev...

    Filing Type:    PU
    Fibrocell Science Inc.

    Fibrocell Science Inc.

    Fibrocell is a cell and gene therapy company focused on improving the lives of peo...

    Fibrocell is a cell and gene therapy company fo...

    Filing Type:    PU
    Alexion Pharmaceuticals, Inc.

    Alexion Pharmaceuticals, Inc.

    Alexion (NASDAQ: ALXN) is a global biopharmaceutical company focused on serving pa...

    Alexion (NASDAQ: ALXN) is a global biopharmaceu...

    Filing Type:    PU
    Catalyst Pharmaceuticals, Inc.

    Catalyst Pharmaceuticals, Inc.

    Catalyst Pharmaceuticals is a biopharmaceutical company focused on developing and ...

    Catalyst Pharmaceuticals is a biopharmaceutical...

    Filing Type:    PU
    Audentes Therapeutics, Inc.

    Audentes Therapeutics, Inc.

    Audentes Therapeutics is a leading AAV-based genetic medicines company focused on ...

    Audentes Therapeutics is a leading AAV-based ge...

    Filing Type:    PU
    Scholar Rock Holding Corporation

    Scholar Rock Holding Corporation

    Scholar Rock is a biopharmaceutical company focused on the discovery and developme...

    Scholar Rock is a biopharmaceutical company foc...

    Filing Type:    PU
    ©2026 National Investor Network. All Rights Reserved.